Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutamate Metabolism in Major Depressive Disorder
Chadi G. Abdallah, Lihong Jiang, Henk M. De Feyter, et al.
American Journal of Psychiatry (2014) Vol. 171, Iss. 12, pp. 1320-1327
Open Access | Times Cited: 181

Showing 1-25 of 181 citing articles:

Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Ronald S. Duman, George K. Aghajanian, Gerard Sanacora, et al.
Nature Medicine (2016) Vol. 22, Iss. 3, pp. 238-249
Open Access | Times Cited: 1367
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman, Gerard Sanacora, John H. Krystal
Neuron (2019) Vol. 102, Iss. 1, pp. 75-90
Open Access | Times Cited: 786
Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods
Cláudia Barth, Arno Villringer, Julia Sacher
Frontiers in Neuroscience (2015) Vol. 9
Open Access | Times Cited: 578
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener, Mark J. Niciu, Elizabeth D. Ballard, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 10, pp. 886-897
Open Access | Times Cited: 414
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 7, pp. 472-486
Closed Access | Times Cited: 413
Brain GABA levels across psychiatric disorders: A systematic literature review and meta‐analysis of 1H‐MRS studies
Remmelt R. Schür, Luc W.R. Draisma, Jannie P. Wijnen, et al.
Human Brain Mapping (2016) Vol. 37, Iss. 9, pp. 3337-3352
Open Access | Times Cited: 308
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi, Akihiro Takamiya, Yoshihiro Noda, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 7, pp. 952-964
Open Access | Times Cited: 290
Ketamine Treatment and Global Brain Connectivity in Major Depression
Chadi G. Abdallah, Lynnette A. Averill, Katherine A. Collins, et al.
Neuropsychopharmacology (2016) Vol. 42, Iss. 6, pp. 1210-1219
Open Access | Times Cited: 271
Glutamate and GABA in autism spectrum disorder—a translational magnetic resonance spectroscopy study in man and rodent models
Jamie Horder, Marija M. Petrinovic, María Andreina Méndez, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 256
Kynurenine pathway in depression: A systematic review and meta-analysis
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 90, pp. 16-25
Closed Access | Times Cited: 242
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Chadi G. Abdallah, Henk M. De Feyter, Lynnette A. Averill, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2154-2160
Open Access | Times Cited: 187
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Paulo Pinares-Garcia, Marielle Stratikopoulos, Alice Zagato, et al.
Brain Sciences (2018) Vol. 8, Iss. 8, pp. 154-154
Open Access | Times Cited: 170
Candidate biomarkers in psychiatric disorders: state of the field
Anissa Abi‐Dargham, Scott J. Moeller, Farzana Ali, et al.
World Psychiatry (2023) Vol. 22, Iss. 2, pp. 236-262
Open Access | Times Cited: 161
O-GlcNAc transferase in astrocytes modulates depression-related stress susceptibility through glutamatergic synaptic transmission
Jun Fan, Fang Guo, Ran Mo, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 7
Open Access | Times Cited: 44
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?
Xin Du, Terence Y. Pang
Frontiers in Psychiatry (2015) Vol. 6
Open Access | Times Cited: 171
The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence
Giuliana S. Zuccoli, Verônica M. Saia‐Cereda, Juliana Nascimento, et al.
Frontiers in Neuroscience (2017) Vol. 11
Open Access | Times Cited: 142
Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications
Ebrahim Haroon, Andrew H. Miller
Current topics in behavioral neurosciences (2016), pp. 173-198
Closed Access | Times Cited: 130
Extensive use of monosodium glutamate: A threat to public health?
Kamal Niaz, Elizabeta Zaplatić, Jochem K. H. Spoor
PubMed (2018) Vol. 17, pp. 273-278
Closed Access | Times Cited: 121
The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
Chadi G. Abdallah, Andrea Parolin Jackowski, Ramiro Salas, et al.
Neuropsychopharmacology (2017) Vol. 42, Iss. 8, pp. 1739-1746
Open Access | Times Cited: 120
Online Effects of Transcranial Direct Current Stimulation in Real Time on Human Prefrontal and Striatal Metabolites
Antoine Hone‐Blanchet, Richard A.E. Edden, Shirley Fecteau
Biological Psychiatry (2015) Vol. 80, Iss. 6, pp. 432-438
Open Access | Times Cited: 107
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Ajay Sarawagi, Narayan Datt Soni, Anant B. Patel
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 100
The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment
Anna Giménez‐Palomo, Seetal Dodd, Gerard Anmella, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 97
Biomarkers for major depressive and bipolar disorders using metabolomics: A systematic review
Kellie MacDonald, Ankur Krishnan, Emily Cervenka, et al.
American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2018) Vol. 180, Iss. 2, pp. 122-137
Closed Access | Times Cited: 96
Meta-analysis of central and peripheral γ-aminobutyric acid levels in patients with unipolar and bipolar depression
Bruno Roméo, Walid Choucha, Philippe Fossati, et al.
Journal of Psychiatry and Neuroscience (2017) Vol. 43, Iss. 1, pp. 58-66
Open Access | Times Cited: 90
Energy metabolism in major depressive disorder: Recent advances from omics technologies and imaging
Xinyi Gu, Shuang Ke, Qixue Wang, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111869-111869
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top